Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lipovax-F5C-TB
- Development stage
- Preclinical
- Lead developer
- Lipotek
- Modality
- Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
01
Overview
Lipovax-F5C-TB is a preclinical liposome-based vaccine candidate developed by Lipotek for the prevention or treatment of tuberculosis (TB). Utilizing Lipotek's proprietary Lipovax platform, the vaccine is designed to deliver specific tuberculosis antigens, identified as F5C, within a liposomal formulation to the immune system. This delivery mechanism is intended to enhance the presentation of TB-specific antigens to immune cells, thereby inducing a robust and protective immune response against *Mycobacterium tuberculosis*. The project is being developed in collaboration with PT Rio Farma.
- Other names
- Lipovax-F5C-TB-Lipotek-liposome-based vaccine-vaccine-TuberculosisLipovax-F-5C-TB-Lipotek-liposome-based vaccine-vaccine-TuberculosisLipovax-F 5C-TB-Lipotek-liposome-based vaccine-vaccine-Tuberculosis
Beyond the preview
Go deeper on Lipovax-F5C-TB.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lipovax-F5C-TB.